Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 36, 2024 - Issue 5
61
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Injecting drug use increases the risk of death in HIV patients on antiretroviral therapy in Vietnam

ORCID Icon, , , , , , , , , , , , & show all
Pages 631-640 | Received 12 Oct 2022, Accepted 07 Jun 2023, Published online: 20 Jun 2023

References

  • Amirkhanian, Y. A., Kelly, J. A., DiFranceisco, W. J., Kuznetsova, A. V., Tarima, S. S., Yakovlev, A. A., & Musatov, V. B. (2018). Predictors of HIV care engagement, antiretroviral medication adherence, and viral suppression among people living with HIV infection in St. Petersburg, Russia. AIDS and Behavior, 22(3), 791–799. https://doi.org/10.1007/s10461-016-1638-9
  • April, M. D., Wood, R., Berkowitz, B. K., Paltiel, A. D., Anglaret, X., Losina, E., Freedberg, K. A., & Walensky, R. P. (2014). The survival benefits of antiretroviral therapy in South Africa. The Journal of Infectious Diseases, 209(4), 491–499. https://doi.org/10.1093/infdis/jit584
  • Benjamins, M. R., Saiyed, N., Bunting, S., Lorenz, P., Hunt, B., Glick, N., & Silva, A. (2021). HIV mortality across the 30 largest U.S. cities: Assessing overall trends and racial inequities. AIDS Care, 1–10. https://doi.org/10.1080/09540121.2021.1939849
  • Cuong, D. D., Sönnerborg, A., Van Tam, V., El-Khatib, Z., Santacatterina, M., Marrone, G., Chuc, N. T. K., Diwan, V., Thorson, A., Le, N. K., An, P. N., & Larsson, M. (2016). Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy – a cluster randomized controlled trial in Vietnam. BMC Infectious Diseases, 16(1), 759. https://doi.org/10.1186/s12879-016-2017-x
  • Dat, V. Q., Lyss, S., Dung, N. T. H., Hung, L. M., Pals, S. L., Anh, H. T. V., Kinh, N. V., & Bateganya, M. (2021). Prevalence of advanced HIV disease, Cryptococcal Antigenemia, and suboptimal clinical outcomes among those enrolled in care in Vietnam. JAIDS Journal of Acquired Immune Deficiency Syndromes, 88(5), 487–496. https://doi.org/10.1097/QAI.0000000000002786
  • Egger, M., May, M., Chêne, G., Phillips, A. N., Ledergerber, B., Dabis, F., Costagliola, D., D’Arminio Monforte, A., de Wolf, F., Reiss, P., Lundgren, J. D., Justice, A. C., Staszewski, S., Leport, C., Hogg, R. S., Sabin, C. A., Gill, M. J., Salzberger, B., Sterne, J. A. C., & ART Cohort Collaboration. (2002). Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. The Lancet, 360(9327), 119–129. https://doi.org/10.1016/s0140-6736(02)09411-4
  • Farhadian, N., Karami Matin, B., Farnia, V., Zamanian, M. H., Najafi, F., & Farhadian, M. (2022). The prevalence of people who inject drugs among those with HIV late presentation: A meta-analysis. Substance Abuse Treatment, Prevention, and Policy, 17(1), 11. https://doi.org/10.1186/s13011-022-00439-5
  • Ferradini, L., Jeannin, A., Pinoges, L., Izopet, J., Odhiambo, D., Mankhambo, L., Karungi, G., Szumilin, E., Balandine, S., Fedida, G., Carrieri, M. P., Spire, B., Ford, N., Tassie, J.-M., Guerin, P. J., & Brasher, C. (2006). Scaling up of highly active antiretroviral therapy in a rural district of Malawi: An effectiveness assessment. The Lancet, 367(9519), 1335–1342. https://doi.org/10.1016/S0140-6736(06)68580-2
  • Fine, J. P., & Gray, R. J. (1999). A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association, 94(446), 496–509. https://doi.org/10.1080/01621459.1999.10474144
  • Frijters, E. M., Hermans, L. E., Wensing, A. M. J., Devillé, W. L. J. M., Tempelman, H. A., & De Wit, J. B. F. (2020). Risk factors for loss to follow-up from antiretroviral therapy programmes in low-income and middle-income countries. AIDS (London, England), 34(9), 1261–1288. https://doi.org/10.1097/QAD.0000000000002523
  • Geskus, R. B. (2011). Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics, 67(1), 39–49. https://doi.org/10.1111/j.1541-0420.2010.01420.x
  • Green, T. C., McGowan, S. K., Yokell, M. A., Pouget, E. R., & Rich, J. D. (2012). HIV infection and risk of overdose: A systematic review and meta-analysis. AIDS (London, England), 26(4), 403–417. https://doi.org/10.1097/QAD.0b013e32834f19b6
  • Han, W. M., Law, M. G., Choi, J. Y., Ditangco, R., Kumarasamy, N., Chaiwarith, R., Ly, P. S., Khusuwan, S., Merati, T. P., Do, C. D., Yunihastuti, E., Azwa, I., Lee, M., Pham, T. N., Chan, Y., Kiertiburanakul, S., Ng, O. T., Tanuma, J., Pujari, S., … Rupasinghe, D. (2021). Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIV. HIV Medicine, hiv.13211. https://doi.org/10.1111/hiv.13211
  • Heath, A. J., Kerr, T., Ti, L., Kaplan, K., Suwannawong, P., Wood, E., & Hayashi, K. (2016). Healthcare avoidance by people who inject drugs in Bangkok, Thailand. Journal of Public Health, 38(3), e301–e308. https://doi.org/10.1093/pubmed/fdv143
  • Iryawan, A. R., Stoicescu, C., Sjahrial, F., Nio, K., & Dominich, A. (2022). The impact of peer support on testing, linkage to and engagement in HIV care for people who inject drugs in Indonesia: Qualitative perspectives from a community-led study. Harm Reduction Journal, 19(1), 16. https://doi.org/10.1186/s12954-022-00595-8
  • Jung, I. Y., Rupasinghe, D., Woolley, I., O’Connor, C. C., Giles, M., Azwa, R. I., Choi, J. Y., & IeDEA Asia-Pacific. (2019). Trends in mortality among ART-treated HIV-infected adults in the Asia-Pacific region between 1999 and 2017: Results from the TREAT Asia HIV observational database (TAHOD) and Australian HIV observational database (AHOD) of IeDEA Asia-Pacific. Journal of the International AIDS Society, 22(1), e25219. https://doi.org/10.1002/jia2.25219
  • Koech, E., Stafford, K. A., Mutysia, I., Katana, A., Jumbe, M., Awuor, P., Lavoie, M.-C., Ngunu, C., Riedel, D. J., & Ojoo, S. (2021). Factors associated with loss to follow-up among patients receiving HIV treatment in Nairobi, Kenya. AIDS Research and Human Retroviruses, 37(9), 642–646. https://doi.org/10.1089/aid.2020.0292
  • Lambert, P. C. (2017). The estimation and modeling of cause-specific cumulative incidence functions using time-dependent weights. The Stata Journal: Promoting Communications on Statistics and Stata, 17(1), 181–207. https://doi.org/10.1177/1536867X1701700110
  • Lan, C.-W., Lin, C., Thanh, D. C., & Li, L. (2018). Drug-related stigma and access to care among people who inject drugs in Vietnam. Drug and Alcohol Review, 37(3), 333–339. https://doi.org/10.1111/dar.12589
  • Laut, K. G., Shepherd, L., Gottfredsson, M., Sedlacek, D., Knysz, B., Begovac, J., Radoi, R., Schmied, B., Chkhartishvili, N., Florence, E., Ristola, M., Fätkenheuer, G., Mulcahy, F., Schmid, P., Kuzovatova, E., Paduta, D., Smidt, J., Domingo, P., Szlávik, J., … Kirk, O. (2018). Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations. AIDS (London, England), 32(18), 2807–2819. https://doi.org/10.1097/QAD.0000000000002035
  • May, M. T., Justice, A. C., Birnie, K., Ingle, S. M., Smit, C., Smith, C., Neau, D., Guiguet, M., Schwarze-Zander, C., Moreno, S., Guest, J. L., d’Arminio Monforte, A., Tural, C., Gill, M. J., Bregenzer, A., Kirk, O., Saag, M., Sterling, T. R., Crane, H. M., & Sterne, J. A. C. (2015). Injection drug use and Hepatitis C as risk factors for mortality in HIV-infected individuals: The antiretroviral therapy cohort collaboration. JAIDS Journal of Acquired Immune Deficiency Syndromes, 69(3), 348–354. https://doi.org/10.1097/QAI.0000000000000603
  • Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., d’Arminio Monforte, A., Knysz, B., Dietrich, M., Phillips, A. N., Lundgren, J. D., & EuroSIDA study group. (2003). Decline in the AIDS and death rates in the EuroSIDA study: An observational study. The Lancet, 362(9377), 22–29. https://doi.org/10.1016/s0140-6736(03)13802-0
  • Nguyen, H. H., Bui, D. D., Dinh, T. T., Pham, L. Q., Nguyen, V. T., Tran, T. H., Pham, T. H., Nguyen, S. M., Suthar, A. B., Do, N. T., Ford, N., Lo, Y.-R., Nguyen, L. H., Giang, L. M., Kato, M., & the team for the implementation research project “Vietnam HIV early antiretroviral therapy with regular HIV testing (V-HEART)”. (2018). A prospective “test-and-treat” demonstration project among people who inject drugs in Vietnam. Journal of the International AIDS Society, 21(7), e25151. https://doi.org/10.1002/jia2.25151
  • Nguyen, T. A., Tran, T. H., Nguyen, B. T., Pham, T. T. P., Hong Le, N. T., Ta, D. V., Phan, H. T. T., Nguyen, L. H., Ait-Ahmed, M., Ho, H. T., Taieb, F., Madec, Y., & for the MOVIDA 2 study group. (2020). Feasibility of dried blood spots for HIV viral load monitoring in decentralized area in North Vietnam in a test-and-treat era, the MOVIDA project. Plos One, 15(4), e0230968. https://doi.org/10.1371/journal.pone.0230968
  • Singh, K., Chander, G., Lau, B., Edwards, J. K., Moore, R. D., & Lesko, C. R. (2019). Association of history of injection drug use with external cause-related mortality among persons linked to HIV care in an urban clinic, 2001–2015. AIDS and Behavior, 23(12), 3286–3293. https://doi.org/10.1007/s10461-019-02497-6
  • Suárez-García, I., Sobrino-Vegas, P., Dalmau, D., Rubio, R., Iribarren, J. A., Blanco, J. R., Gutierrez, F., Montero Alonso, M., Bernal, E., Vinuesa García, D., Del Amo, J., & Cohort of the Spanish HIV Research Network (CoRIS). (2016). Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: Late presentation, delayed anti-retroviral treatment and higher mortality. Addiction, 111(7), 1235–1245. https://doi.org/10.1111/add.13348
  • Taieb, F., Tran Hong, T., Ho, H. T., Nguyen Thanh, B., Pham Phuong, T., Viet Ta, D., Le Thi Hong, N., Ba Pham, H., Nguyen, L. T. H., Nguyen, H. T., Nguyen, T. T., Tuaillon, E., Delaporte, E., Le Thi, H., Tran Thi Bich, H., Nguyen, T. A., & Madec, Y. (2018). First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting in Vietnam. PloS One, 13(2), e0191920. https://doi.org/10.1371/journal.pone.0191920
  • Tanuma, J., Matsumoto, S., Haneuse, S., Cuong, D. D., Vu, T. V., Thuy, P. T. T., Dung, N. T., Dung, N. T. H., Trung, N. V., Kinh, N. V., & Oka, S. (2017). Long-term viral suppression and immune recovery during first-line antiretroviral therapy: A study of an HIV-infected adult cohort in Hanoi, Vietnam. Journal of the International AIDS Society, 20(4), e25030. https://doi.org/10.1002/jia2.25030
  • Tiendrebeogo, T., Messou, E., Arikawa, S., Ekouevi, D. K., Tanon, A., Kwaghe, V., Balestre, E., Zannou, M. D., Poda, A., Dabis, F., Jaquet, A., Minga, A., Becquet, R., & IeDEA West Africa Collaboration. (2021). Ten-year attrition and antiretroviral therapy response among HIV-positive adults: A sex-based cohort analysis from eight West African countries. Journal of the International AIDS Society, 24(5), https://doi.org/10.1002/jia2.25723
  • Tran, D. A., Shakeshaft, A., Ngo, A. D., Mallitt, K.-A., Wilson, D., Doran, C., & Zhang, L. (2013). Determinants of antiretroviral therapy initiation and treatment outcomes for people living with HIV in Vietnam. HIV Clinical Trials, 14(1), 21–33. https://doi.org/10.1310/hct1401-21
  • UNAIDS. (n.d.). Viet Nam. Retrieved April 14, 2023, from https://www.unaids.org/en/regionscountries/countries/vietnam
  • Van Nguyen, H., Nguyen, H. L. T., Mai, H. T., Le, H. Q., Tran, B. X., Hoang, C. D., Le, H. T., Nguyen, C. T., Tran, T. D., Latkin, C. A., & Vu, T. M. T. (2017). Stigmatization among methadone maintenance treatment patients in mountainous areas in northern Vietnam. Harm Reduction Journal, 14(1), 1. https://doi.org/10.1186/s12954-016-0127-9
  • Walensky, R. P., Paltiel, A. D., Losina, E., Mercincavage, L. M., Schackman, B. R., Sax, P. E., Weinstein, M. C., & Freedberg, K. A. (2006). The survival benefits of AIDS treatment in the United States. The Journal of Infectious Diseases, 194(1), 11–19. https://doi.org/10.1086/505147
  • World Health Organization. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach (2nd ed.). https://apps.who.int/iris/handle/10665/208825
  • World Health Organization. (n.d.). HIV data and statistics. Retrieved April 14, 2023, from https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/tick-borne-encephalitis/hiv
  • Zaniewski, E., Dao Ostinelli, C. H., Chammartin, F., Maxwell, N., Davies, M., Euvrard, J., Dijk, J., Bosomprah, S., Phiri, S., Tanser, F., Sipambo, N., Muhairwe, J., Fatti, G., Prozesky, H., Wood, R., Ford, N., Fox, M. P., & Egger, M. (2020). Trends in CD4 and viral load testing 2005 to 2018: Multi-cohort study of people living with HIV in Southern Africa. Journal of the International AIDS Society, 23(7), https://doi.org/10.1002/jia2.25546
  • Zhu, J., Yousuf, M. A., Yang, W., Zhu, Q., Shen, Z., Lan, G., Chen, Y., Chen, H., Fan, W., Xing, H., Shao, Y., Ruan, Y., & Li, L. (2021). Mortality and attrition rates within the first year of antiretroviral therapy initiation among people living with HIV in Guangxi, China: An observational cohort study. BioMed Research International, 2021, 1–10. https://doi.org/10.1155/2021/6657112

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.